Erin Graves | executive |
Mark Goldsmith | executive |
Jack Anders | executive |
Marc Frahm | analyst |
Stephen Kelsey | executive |
Eric Joseph | analyst |
Jonathan Chang | analyst |
Charles Ferranti | analyst |
Ami Fadia | analyst |
Alec Stranahan | analyst |
Good day, and thank you for standing by. Welcome to the Revolution Medicines Q3 2023 Earnings Conference Call. [Operator Instructions]. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker, Erin Graves, Senior Director of Corporate Communications and Investor Relations. Please go ahead.